Patents by Inventor Petra Bacher

Petra Bacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9770495
    Abstract: The present invention provides the in-vitro use of at least one in-vivo-target antigen of Aspergillus fumigatus for selective activation, detection and/or analysis of Aspergillus fumigatus specific CD4+ T cells in a sample comprising cells, wherein said at least one in-vivo-target antigen reveals an immune reactivity characterized by i) the in vivo existence of antigen-specific T cells comprising more than 60% memory T cells and ii) said antigen-specific T cells further comprise T cells able to produce IFN-gamma upon stimulation at a frequency between 15% and 80% and/or IL17 upon stimulation at a frequency between 5% and 30%. Said at least one in-vivo-target antigen may be selected from the group consisting of antigens Scw4, Pst1, Shm2, GliT and TpiA or fragments thereof. Also provided are a method, a composition, and a kit thereof.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: September 26, 2017
    Assignees: MILTENYI BIOTEC GMBH, Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute
    Inventors: Alexander Scheffold, Petra Bacher, Olaf Kniemeyer, Janka Teutschbein, Axel Brakhage
  • Publication number: 20160047809
    Abstract: The present invention provides the in-vitro use of at least one in-vivo-target antigen of Aspergillus fumigatus for selective activation, detection and/or analysis of Aspergillus fumigatus specific CD4+ T cells in a sample comprising cells, wherein said at least one in-vivo-target antigen reveals an immune reactivity characterized by i) the in vivo existence of antigen-specific T cells comprising more than 60% memory T cells and ii) said antigen-specific T cells further comprise T cells able to produce IFN-gamma upon stimulation at a frequency between 15% and 80% and/or IL17 upon stimulation at a frequency between 5% and 30%. Said at least one in-vivo-target antigen may be selected from the group consisting of antigens Scw4, Pst1, Shm2, GliT and TpiA or fragments thereof. Also provided are a method, a composition, and a kit thereof.
    Type: Application
    Filed: August 12, 2015
    Publication date: February 18, 2016
    Applicants: MILTENYI BIOTEC GMBH, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoll Institute
    Inventors: Alexander SCHEFFOLD, Petra BACHER, Olaf KNIEMEYER, Janka TEUTSCHBEIN, Axel BRAKHAGE
  • Publication number: 20120276557
    Abstract: The invention relates to a method for sensitive quantitative and/or qualitative analysis of target T cells comprising the steps a) enrichment of said cells from a mixture of said cells and other cells in a sample by the use of one or more activation markers expressed on antigen-activated T cells in a parallel cell sorting process and b) analysis of the cells of step a). The invention relates also to a method of diagnosing diseases based on the analysis of the target T cells.
    Type: Application
    Filed: April 27, 2012
    Publication date: November 1, 2012
    Inventors: Alexander SCHEFFOLD, Petra Bacher